A recent preprint study examining Pfizer and BioNTech’s COVID-19 shot in children and adolescents raises serious concerns about its safety profile. The large study, which involved more than 1.7 million children aged 5 to 15, found cases of pericarditis, a disease characterized by inflammation of the heart, only in vaccinated children. It became clear.
Testing the effectiveness of Pfizer’s shot
The study, published on OpenSAFELY, a British open-source medical platform, provides compelling evidence that Pfizer-BioNTech’s BNT162b2 shot protects against the virus for only 14 to 15 weeks.1
The limited scope of envisaged protection adds another layer to the debate about whether the benefits of the jab outweigh the risks for young people. The findings are particularly important because they challenge the long-held notion that vaccinating children against COVID-19 improves their outcomes against the disease.
A key dataset was provided by the UK National Health Service (NHS) for analysis. The researchers selected children aged 5 to 11 years and adolescents aged 12 to 15 years and examined their region, evidence of previous infection, previous vaccination status, other childhood vaccinations, and second dose. vaccination (for comparison). .
Children who were clinically vulnerable or had a history of COVID-19 prior to vaccination were excluded to ensure that the sample was concentrated in children who were generally healthy before vaccination.2
Does the new coronavirus infection vaccination really protect the recipient?
Using different analytical methods, researchers were able to gather a variety of information about the effectiveness of the BNT162b2 shot. Again, the first and most surprising discovery was that the shot only gave “protection” for 14 to 15 weeks.3
“By 14 weeks, the cumulative incidence of positive SARS-CoV-2 tests was similar in the second-dose and single-dose groups,” the researchers said.4 In a report for The Defender, Dr. Brenda Baretti summarizes other findings:5
“Of the 1,262,784 adolescents studied (vaccinated and unvaccinated), only 72 had emergency department visits and 90 were hospitalized for COVID-19, of which 3 were vaccinated and unvaccinated. This was a life-saving emergency for a child, and there were no fatalities.
There were nine cases of pericarditis and three cases of myocarditis, all in the vaccinated group. ”
With these findings, British researchers add to a confirmed and growing body of evidence linking COVID-19 vaccination to myocarditis and pericarditis in young people.6 Additionally, the jab slightly reduced emergency room visits and hospitalizations, but these events were rare across all groups, with and without the jab. Furthermore, no deaths were recorded among the study population.7
Hospitalizations were slightly more frequent in the one-dose group compared to the two-dose group. Although the study results may suggest that two doses are an effective deterrent, Dr. Brian Hooker, chief scientific officer at Children’s Health Defense, said that “healthy vaccine recipients He proposes another theory called “effect.” This was true for those who experienced adverse events after the first dose, leading to increased hospitalizations. As a result, these children were not able to receive their second dose.
Public health is at risk due to the spread of COVID-19
The OpenSAFELY study sheds important light on a topic I have been discussing for a long time. This means that vaccinating against COVID-19 ultimately puts public health at risk, whether it’s for children or adults. Already in 2021, an increase in myocarditis cases was evident soon after vaccination, which I explored in my article, “Myocarditis triples in Pfizer vaccine study.” Israeli researchers published their findings in the New England Journal of Medicine, pointing out the following:8
“The risk appears to be highest among young men. We found a three-fold increase in the risk of myocarditis after vaccination, which equates to approximately three excess events per 100,000 men. The 95% confidence interval indicated that a value of 1 to 5 excess events per 100,000 people was consistent with the data.
Among the 21 patients with myocarditis in the vaccinated group, the median age was 25 years (interquartile range, 20-34 years) and 90.9% were male. ”
Despite the published research results, people around the world are still receiving mRNA injections. In May 2024, I published an article examining the continuing problem of myocarditis causing myocarditis in more and more people.
I believe that the public has a right to know the truth about what is going on, but the authorities are keeping us in the dark. Despite filing a Freedom of Information Act (FOIA) request, the U.S. Centers for Disease Control and Prevention (CDC) responded with a fully redacted document.9
And, as evidenced by the OpenSAFELY study, heart problems are still ongoing. It is clear that mRNA COVID-19 vaccines are among the most dangerous drugs ever released. To end violence against our youth, please tell your friends and family to avoid shooting in the first place. People who have already been vaccinated should not receive any more booster shots.
Has your child been vaccinated against COVID-19?
If your child has been vaccinated, or your child knows a parent who has been vaccinated, there are strategies available to repair the toxic attack on the body. I recommend the I-RECOVER program by the Front Line COVID-19 Critical Care Alliance (FLCCC). On their website you will find two ways to approach management – Long COVID-1910 And a post jab.11
The World Health Council has also published an extensive database of treatments to help suppress and eliminate the spike protein. Most experts agree that the spike protein is the main cause of adverse events caused by the shot.12 For additional strategies to help protect children, I recommend reading my article “Identifying Long-Term COVID-19 Infections in Children and Adolescents.” There, we discuss the importance of probiotics, melatonin, and NAD+ in boosting the body’s defenses.
It is also helpful to learn about the symptoms of pericarditis and myocarditis. Both affect the heart, but they manifest in different ways. Myocarditis refers to inflammation of the myocardium, the actual heart muscle. Pericarditis, on the other hand, refers to inflammation of the pericardium, the sac-like layer that surrounds the heart.13 According to the Ann & Robert H. Lurie Children’s Hospital of Chicago, symptoms to watch for include:14
| myocarditis | Pericarditis |
|---|---|
| fatigue | Chest pain is worse when lying down and better when sitting. |
| shortness of breath | heat |
| abnormal heart rhythm | shortness of breath |
| lightheadedness or fainting | increased heart rate and/or decreased blood pressure |
